Your Ad Here
PatientsVille.com> Naropeine Report List> Naropeine Side Effects
If You had Naropeine side effect, You are not alone. Other patients reported side effects.
Do You Have Naropeine Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Naropeine Community

Ask patient community about Naropeine related health issues.

View FDA Reports

Naropeine adverse events reported to FDA.

Have You Experienced unusual Naropeine symptoms? PatientsVille.com collects and analyzes Naropeine side effect and adverse reports submitted by Naropeine users, such as .

Summary

FDA Adverse Reports: 22. View All

Naropeine FDA safety alerts: No

Reported deaths: 5

Reported hospitalizations: 10

More About Naropeine

Post Your Unusual Symptoms:

Most Reported
Recent Drug Reports

More Naropeine Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Naropeine, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Naropeine users, Learn more about unwanted side effects & find ways to reduce them. Browse Naropeine Adverse Reports reported to FDA and participate in Naropeine discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Naropeine. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Naropeine Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

6019463-3 | Monoplegia
on Dec 18, 2008 Female patient from FRANCE , 24 years of age, was diagnosed with nerve block, postoperative care, prophylaxis of nausea and vomiting and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: monoplegia. Naropeine dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), SEVORANE (View Sevorane Review and Sevorane Label ).

5947026-4 | Hypotonia Neonatal
Patient was taking Naropeine (View Usage). Patient had the following side effects: hypotonia neonatal on Oct 30, 2008 from FRANCE Additional patient health information: Male patient , weighting 8.38 lb, . Naropeine dosage: . Patient was hospitalized.

5835476-6 | Bradycardia, Convulsion, Oxygen Saturation Decreased, Rash
Adverse event was reported on Jul 30, 2008 by a Male patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: FRANCE , weighting 68.34 lb, After Naropeine was administered, patient had the following side effects: bradycardia, convulsion, oxygen saturation decreased, rash (What is rash?). During the same period patient was treated with MOPRAL (View Mopral Review and Mopral Label ), SUFENTA (View Sufenta Review and Sufenta Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NALBUPHINE (View Nalbuphine Review and Nalbuphine Label ). Patient was hospitalized.

5828553-7 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jul 21, 2008 Female patient from FRANCE , 45 years of age, weighting 154.3 lb, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.


5806051-4 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jul 01, 2008 Female patient from FRANCE , 45 years of age, weighting 154.3 lb, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5760000-6 | Hypotension
Patient was taking Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: hypotension on Jun 02, 2008 from FRANCE Additional patient health information: Female patient , 75 years of age, . Naropeine dosage: .

5568632-5 |
Adverse event was reported on Dec 07, 2007 by a Male patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, antibiotic prophylaxis, pain (What is pain?), labour pain, anxiety (What is anxiety?) and. Location: FRANCE , weighting 6.39 lb, . During the same period patient was treated with ERYTHROMYCIN ETHYLSUCCINATE (View Erythromycin Ethylsuccinate Review and Erythromycin Ethylsuccinate Label ), SUFENTA (View Sufenta Review and Sufenta Label ), NUBAIN (View Nubain Review and Nubain Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), ATARAX (View Atarax Review and Atarax Label ).

5386735-5 | Femoral Nerve Injury, Monoplegia, Sensory Loss
on Jul 06, 2007 Female patient from FRANCE , weighting 145.5 lb, was diagnosed with procedural pain and was treated with Naropeine (View Usage). Patient had the following side effects: femoral nerve injury, monoplegia, sensory loss. Naropeine dosage: .

5355921-2 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jun 11, 2007 Female patient from FRANCE , 45 years of age, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5346156-8 | Anaphylactic Shock, Cardiac Arrest, Convulsion
Patient was taking Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion on Jun 01, 2007 from FRANCE Additional patient health information: Female patient , 45 years of age, was diagnosed with local anaesthesia and. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5312689-3 | Cardiac Arrest, Hypoproteinaemia, Overdose, Respiratory Arrest, Ventricular Fibrillation
Adverse event was reported on Apr 26, 2007 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia and. Location: FRANCE , weighting 143.3 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, respiratory arrest, ventricular fibrillation. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5312424-9 | Injection Site Infection
on Apr 26, 2007 Male patient from FRANCE , 59 years of age, was diagnosed with postoperative analgesia, infection prophylaxis and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: injection site infection. Naropeine dosage: . During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

5302181-4 | Paraesthesia, Sciatica
on Apr 17, 2007 Male patient from FRANCE , 55 years of age, was diagnosed with local anaesthesia, liver transplant (What is liver transplant?) and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia, sciatica (What is sciatica?). Naropeine dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ).

5272893-X | Neuromuscular Block Prolonged
Patient was taking Naropeine (View Usage). Patient had the following side effects: neuromuscular block prolonged on Mar 09, 2007 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with local anaesthesia, sedation and. Naropeine dosage: . During the same period patient was treated with HYPNOVEL (View Hypnovel Review and Hypnovel Label ).

5268238-1 | Epilepsy
Adverse event was reported on Mar 05, 2007 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: FRANCE , 26 years of age, After Naropeine was administered, patient had the following side effects: epilepsy (What is epilepsy?).

5249869-1 | Cardiac Arrest, Hypoproteinaemia, Overdose, Respiratory Arrest, Ventricular Fibrillation
on Feb 19, 2007 Female patient from FRANCE , weighting 143.3 lb, was diagnosed with postoperative analgesia and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, respiratory arrest, ventricular fibrillation. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5226256-3 | Cardiac Arrest, Hypoproteinaemia, Overdose, Ventricular Fibrillation
on Jan 19, 2007 Female patient from FRANCE , 65 years of age, was diagnosed with postoperative analgesia and was treated with Naropeine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, ventricular fibrillation. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5223746-4 | Cardiac Arrest, Hyperproteinaemia, Overdose, Ventricular Fibrillation
Patient was taking Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hyperproteinaemia, overdose, ventricular fibrillation on Jan 19, 2007 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with postoperative analgesia and. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5173218-0 | Cardiac Arrest, Overdose, Ventricular Fibrillation
Adverse event was reported on Dec 08, 2006 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia and. Location: FRANCE , 65 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), overdose, ventricular fibrillation. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5164614-6 | Agitation, Cardiac Arrest, Convulsion, Hallucination, Muscle Rigidity, Respiratory Arrest
on Nov 30, 2006 Male patient from FRANCE , 42 years of age, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient had the following side effects: agitation, cardiac arrest (What is cardiac arrest?), convulsion, hallucination, muscle rigidity, respiratory arrest. Naropeine dosage: .

5143405-6 | Peripheral Sensory Neuropathy
on Dec 06, 2005 Male patient from FRANCE , 45 years of age, was diagnosed with local anaesthesia, epilepsy (What is epilepsy?) and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: peripheral sensory neuropathy. Naropeine dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

5136271-6 | Neuromuscular Block Prolonged
Patient was taking Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged on Oct 10, 2006 from FRANCE Additional patient health information: Female patient , 35 years of age, weighting 125.7 lb, was diagnosed with spinal anaesthesia and. Naropeine dosage: . Patient was hospitalized.


Share Your Experience, Join the Discussion:

Go to the top of the page

Naropeine Questions, Answers, Feedback and Comments

No comments have been provided.

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Naropeine risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Naropeine quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Naropeine use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

naropeine Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: naropin Episodes: 2: Diagnosed with major depression.Side ...

Naropeine Review and Naropeine Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), TENORDATE (View Tenordate Review and Tenordate Label ...

During the same period patient was treated with NAROPEINE (40 Ml Of 0.5%) (View Naropeine Review and Naropeine Label ), LIDOCAINE (20 Ml Of 1%) (View Lidocaine Review and ...

... iodine) (povidone-iodine) Review and Betadine (povidone-iodine) (povidone-iodine) Label ), NAROPEINE (ROPIVACAINEHYDROCHLORIDE) (ROPIVACAINE HYDROCHLORIDE) (View Naropeine ...

During the same period patient was treated with NAROPEINE (View Naropeine Review and Naropeine Label ), ULTIVA (0.05 G/kg/minute) (View Ultiva Review and Ultiva Label ), ...

... Dexamethason Merck (dexamethasone Sodium Phosphate) Label ), ACUPAN (View Acupan Review and Acupan Label ), BETADINE (View Betadine Review and Betadine Label ), NAROPEINE ...

During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), NAROPEINE (View Naropeine Review and Naropeine Label ), SUFENTA (View ...

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.

... Eupantol (pantoprazole) Label ), NAROPEINE (ROPIVACAINE HYDROCHLORIDE ANHYDRE) (View Naropeine (ropivacaine Hydrochloride Anhydre) Review and Naropeine (ropivacaine ...

During the same period patient was treated with NAROPEINE (View Naropeine Review and Naropeine Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), ...

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Naropeine Reactions
Agitation
Anaphylactic Shock
Apparent Death
Bradycardia
Cardiac ArrestWhat is Cardiac arrest?
Convulsion
EpilepsyWhat is Epilepsy?
Femoral Nerve Injury
Hallucination
Hyperproteinaemia
Hypoproteinaemia
Hypotension
Hypotonia Neonatal
Injection Site Infection
Monoplegia
Muscle Rigidity
Neuromuscular Block Prolonged
Overdose
Oxygen Saturation Decreased
Paraesthesia
Peripheral Sensory Neuropathy
RashWhat is Rash?
Respiratory Arrest
SciaticaWhat is Sciatica?
Sensory Loss
Sudden Death
Ventricular Fibrillation
Naropeine Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Naropeine adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!